2,869
edits
Psychedelics: Difference between revisions
m
→Usage
m (→Usage) |
|||
| Line 38: | Line 38: | ||
== Usage == | == Usage == | ||
[[File: | [[File:Psychedelics relative harm.jpg|alt=Economist relative harm|thumb|'''Figure 3'''. Relative harm of drugs<ref>'''Drug harms in the UK''': a multicriteria decision analysis Prof David J Nutt, FMedSci, Leslie A King, PhD, Lawrence D Phillips, PhD on behalf of the Independent Scientific Committee on Drugs Published:November 01, 2010. DOI:https://doi.org/10.1016/S0140-6736(10)61462-6</ref>.]] | ||
Like all medicines, psychedelics are not without potential harm. However, relative to all other drugs (See '''Figure 3''') risk associated with their use is minimal. In a clinical sense, under specific [[priming]] and [[setting]] there is abundant evidence for the safety and efficacy for their use in the treatment of: | Like all medicines, psychedelics are not without potential harm. However, relative to all other drugs (See '''Figure 3''') risk associated with their use is minimal. In a clinical sense, under specific [[priming]] and [[setting]] there is abundant evidence for the safety and efficacy for their use in the treatment of: | ||